Subjective Visual Vertical Test Has Low Sensitivity for Identifying Meniere Disease
By Elana Gotkine HealthDay Reporter
FRIDAY, Aug. 2, 2024 -- The subjective visual vertical (SVV) test has relatively low sensitivity for diagnosing Meniere disease, according to a study published in the July and August issue of the Iranian Journal of Otorhinolaryngology.
Hadi Behzad, Ph.D., from the Shahid Beheshti University of Medical Science in Tehran, Iran, and colleagues conducted a study on 53 patients with confirmed unilateral Meniere disease and a control group to examine use of the SVV test in static and dynamic models as well as the electrocochleography (ECochG) test for diagnosing Meniere disease.
The researchers found that the optimal cutoff point obtained for the tilt toward the lesion was 2.1 degrees of deviation, which had sensitivity of 0.698 and specificity of 0.717. This was identified as the best condition for differentiating individuals with Meniere disease from the healthy control group, but the levels of sensitivity and specificity were considered relatively low for an auditory test and unreliable in terms of diagnosis.
"Based on the current findings, the SVV test has relatively low sensitivity for diagnosing Meniere's disease. Therefore, relying solely on its results to identify Meniere's disease is not recommended," the authors write. "Future studies should explore other avenues besides using ECochG and SVV tests together."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2024
Read this next
Casual Blood Glucose Testing Misses ~70 Percent of Gestational Diabetes Cases
FRIDAY, Sept. 27, 2024 -- Casual blood glucose (CBG) testing at 24 to 28 gestational weeks misses about 70 percent of women with gestational diabetes mellitus (GDM), according to...
Large Difference in Survival Seen for Preemies Born at 25 Versus 22 Weeks
FRIDAY, Sept. 27, 2024 -- For infants born prematurely, survival increases considerably for those born at 25 versus 22 gestational weeks, according to a study published online...
Adverse Brain Health Outcomes Increased for Sexual, Gender Minority Groups
FRIDAY, Sept. 27, 2024 -- Sexual and gender-minority (SGM) persons have increased odds of adverse brain health outcomes, according to a study published online Sept. 25 in...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.